| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,777 | 12,037 | 14,880 | 16,324 | | Cost of Revenue | 7,585 | 8,903 | 10,232 | 10,054 | | | Gross Profit | 4,192 | 3,134 | 4,648 | 6,270 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,139 | 4,655 | 4,742 | 4,803 | | Non Recurring |
-
|
-
|
-
| 23,854 | | Others | 690 | 694 | 708 | 837 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (637) | (2,215) | (802) | (23,224) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | 45 | 68 | 141 | | Earnings Before Interest And Taxes | (645) | (2,170) | (734) | (23,083) | | Interest Expense |
-
|
-
|
-
| 51 | | Income Before Tax | (645) | (2,170) | (734) | (23,134) | | Income Tax Expense | (396) | (892) | (280) | 4,785 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (249) | (1,278) | (454) | (27,919) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (249) | (1,278) | (454) | (27,919) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($249) | ($1,278) | ($454) | ($27,919) |
|
0.51% Nasdaq 
0.01 (0.34%) 
Income Statement
